Literature DB >> 35506765

Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.

Kyle M Stiers1, Luckio F Owuocha1, Lesa J Beamer1.   

Abstract

Phosphoglucomutase 1 (PGM1) plays a central role in glucose homeostasis in human cells. Missense variants of this enzyme cause an inborn error of metabolism, which is categorized as a congenital disorder of glycosylation. Here, two disease-related variants of PGM1, T337M and G391V, which are both located in domain 3 of the four-domain protein, were characterized via X-ray crystallography and biochemical assays. The studies show multiple impacts resulting from these dysfunctional variants, including both short- and long-range structural perturbations. In the T337M variant these are limited to a small shift in an active-site loop, consistent with reduced enzyme activity. In contrast, the G391V variant produces a cascade of structural perturbations, including displacement of both the catalytic phosphoserine and metal-binding loops. This work reinforces several themes that were found in prior studies of dysfunctional PGM1 variants, including increased structural flexibility and the outsized impacts of mutations affecting interdomain interfaces. The molecular mechanisms of PGM1 variants have implications for newly described inherited disorders of related enzymes.

Entities:  

Keywords:  X-ray crystallography; congenital disorders of glycosylation; enzymes; human phosphoglucomutase 1; inherited diseases; missense variants; structural perturbation

Mesh:

Substances:

Year:  2022        PMID: 35506765      PMCID: PMC9067374          DOI: 10.1107/S2053230X22004174

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.072


  43 in total

1.  Clinical and molecular genetic characterization of two patients with mutations in the phosphoglucomutase 1 (PGM1) gene.

Authors:  Yu Ding; Niu Li; Gouying Chang; Juan Li; Ruen Yao; Yiping Shen; Jian Wang; Xiaodong Huang; Xiumin Wang
Journal:  J Pediatr Endocrinol Metab       Date:  2018-07-26       Impact factor: 1.634

2.  Accessing protein conformational ensembles using room-temperature X-ray crystallography.

Authors:  James S Fraser; Henry van den Bedem; Avi J Samelson; P Therese Lang; James M Holton; Nathaniel Echols; Tom Alber
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-14       Impact factor: 11.205

3.  A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.

Authors:  Belén Pérez; Celia Medrano; Maria Jesus Ecay; Pedro Ruiz-Sala; Mercedes Martínez-Pardo; Magdalena Ugarte; Celia Pérez-Cerdá
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

4.  Assessment and Impacts of Phosphorylation on Protein Flexibility of the α-d-Phosphohexomutases.

Authors:  Kyle M Stiers; Lesa J Beamer
Journal:  Methods Enzymol       Date:  2018       Impact factor: 1.600

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Disease severity and clinical outcome in phosphosglucomutase deficiency.

Authors:  Eva Morava; Sunnie Wong; Dirk Lefeber
Journal:  J Inherit Metab Dis       Date:  2015-03       Impact factor: 4.982

Review 7.  Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1.

Authors:  Lesa J Beamer
Journal:  Biochimie       Date:  2020-09-06       Impact factor: 4.079

8.  Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

Authors:  Atfa Sassi; Sandra Lazaroski; Gang Wu; Stuart M Haslam; Manfred Fliegauf; Fethi Mellouli; Turkan Patiroglu; Ekrem Unal; Mehmet Akif Ozdemir; Zineb Jouhadi; Khadija Khadir; Leila Ben-Khemis; Meriem Ben-Ali; Imen Ben-Mustapha; Lamia Borchani; Dietmar Pfeifer; Thilo Jakob; Monia Khemiri; A Charlotta Asplund; Manuela O Gustafsson; Karin E Lundin; Elin Falk-Sörqvist; Lotte N Moens; Hatice Eke Gungor; Karin R Engelhardt; Magdalena Dziadzio; Hans Stauss; Bernhard Fleckenstein; Rebecca Meier; Khairunnadiya Prayitno; Andrea Maul-Pavicic; Sandra Schaffer; Mirzokhid Rakhmanov; Philipp Henneke; Helene Kraus; Hermann Eibel; Uwe Kölsch; Sellama Nadifi; Mats Nilsson; Mohamed Bejaoui; Alejandro A Schäffer; C I Edvard Smith; Anne Dell; Mohamed-Ridha Barbouche; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2014-04-01       Impact factor: 10.793

9.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13

10.  Limitations of galactose therapy in phosphoglucomutase 1 deficiency.

Authors:  Kristine Nolting; Julien H Park; Laura C Tegtmeyer; Andrea Zühlsdorf; Marianne Grüneberg; Stephan Rust; Janine Reunert; Ingrid Du Chesne; Volker Debus; Eric Schulze-Bahr; Robert C Baxter; Yoshinao Wada; Christian Thiel; Emile van Schaftingen; Ralph Fingerhut; Thorsten Marquardt
Journal:  Mol Genet Metab Rep       Date:  2017-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.